15th Annual On-Demand Comprehensive Hematology & Oncology Review course

Overview

The 15th Annual On-Demand Comprehensive Hematology & Oncology Review Course is an extensive educational program presented by Fred Hutchinson Cancer Center and the University of Washington School of Medicine. This on-demand course delivers expert-reviewed content covering both hematologic disorders and solid tumors, focusing on current therapeutic options, diagnostic evaluation, and pathogenesis. On-demand Oncology & Hematology education — accessible anytime, anywhere.

This program includes videos and PDF materials addressing 54 topics relevant to the clinical practice of hematology and oncology. It is designed to enhance understanding of guideline-based treatments, recent advances, and practical integration of new therapeutic and diagnostic approaches. The content is suitable for examination preparation and ongoing professional development.

Format: Videos and PDFs

Agenda

This course provides a structured review of core topics in hematology and oncology, delivering clinical updates and guideline-supported evidence. Key subject areas include both solid tumors and hematologic malignancies, along with supportive care and associated specialties.

• Breast Oncology Adjuvant Therapy for Breast Cancer — William Gwin, MD
• Breast Oncology Metastatic Breast Cancer — Natasha Hunter, MD
• Breast Oncology Therapy for Non-Invasive Breast Cancer — Rachel Yung, MD
• Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) & Hairy Cell Leukemia — Mazyar Shadman, MD, MPH
• Consultative Hematology
• GI Oncology Anal Cancer — Andrew Coveler, MD
• GI Oncology Cholangiocarcinoma — Gentry King, MD
• GI Oncology Colorectal Cancer — Stacey Cohen, MD
• GI Oncology Esophageal Gastric Cancer — Veena Shankaran, MD
• GI Oncology Gastrointestinal Neuroendocrine Tumors — David Zhen, MD
• GI Oncology Hepatocellular Cancer — William Harris, MD
• GI Oncology Pancreatic Cancer — Rachael Safyan, MD
• GU Oncology Bladder Cancer
• GU Oncology Prostate Cancer — Michael Schweizer, MD
• GU Oncology Renal Cell Carcinoma — Scott Tykodi, MD, PhD
• GU Oncology Testicular Cancer — Todd Yezefski, MD
• Gynecologic Oncology Cervical & Endometrial Cancers — Renata Urban, MD
• Gynecologic Oncology Ovarian Cancer — Kalyan Banda, MD
• Hematology Bleeding Disorders — Rebecca Kruse-Jarres, MD, MPH
• Hematology Hematopoietic Stem Cell Transplantation — Naveed Ali, MD
• Hematology Inherited & Acquired Marrow Failure — Bart Scott, MD
• Hematology Iron Metabolism Disorders & Hemolytic Anemias — Livia Hegerova, MD
• Hematology Myelodysplastic Syndromes — Jacob Appelbaum, MD, PhD
• Hematology Myeloproliferative Neoplasms — Anna Halpern, MD
• Hematology Thalassemia & Hemoglobinopathies — Kleber Fertrin, MD, PhD
• Hematology Thrombocytopenia — Sandhya Panch, MD, MPH
• Hematology Thrombosis & Anticoagulation — David Garcia, MD
• Hematology Transfusion Medicine — Monica Pagano, MD
• Hematology White Cell Disorders — Prakash Vishnu, MD, FACP
• Leukemia & Myelomas Acute Lymphoblastic Leukemia — Ryan Cassaday, MD
• Leukemia & Myelomas Acute Myeloid Leukemia — Mary-Elizabeth Percival, MD
• Leukemia & Myelomas Chronic Myeloid Leukemia — Jacob Appelbaum, MD, PhD
• Leukemia & Myelomas MGUS & Smoldering Myeloma — Mary Kwok, MD
• Leukemia & Myelomas Newly-Diagnosed Myeloma — Andrew Portuguese, MD
• Lymphomas Aggressive Non-Hodgkin Lymphoma — Mengyang Di, MD, PhD
• Lymphomas Hodgkin Lymphoma — Christina Poh, MD
• Lymphomas Indolent Non-Hodgkin Lymphoma — Solomon Graf, MD
• Lymphomas T-Cell Lymphoma — Christina Poh, MD
• Melanoma & Other Skin Cancers — Shailender Bhatia, MD
• Neuro-Oncology CNS Cancers — Vyshak Venur, MD
• Relapsed, Refractory Myeloma & Amyloidosis — Andrew Cowan, MD
• Sarcoma — Lee Cranmer, MD, PhD, FACP
• Supportive Care & Associated Specialties Hematology Pharmacology Pearls — Zak Cerminara, PharmD
• Supportive Care & Associated Specialties Infectious Disease Complications — Danniel Zamora, MD
• Supportive Care & Associated Specialties Integrative Medicine — Shannon Fogh, MD
• Supportive Care & Associated Specialties Solid Tumor Pharmacology Pearls — Amy Indorf, PharmD, BCOP
• Supportive Care Familial Syndromes — Marshall Horwitz, MD, PhD
• Supportive Care — Keith Eaton, MD, PhD
• Supportive Care Radiation Oncology – Multi-disciplinary (Breast, Lung, Colorectal & Palliative) — Jonathan Chen, MD, PhD
• Thoracic, Head & Neck Oncology Head, Neck & Thyroid Cancer — Cristina Rodriguez, MD
• Thoracic, Head & Neck Oncology Mesothelioma — Nicholas Giustini, MD
• Thoracic, Head & Neck Oncology Non-Small Cell Lung Cancer – Adjuvant Locally Advanced — Rafael Santana-Davila, MD
• Thoracic, Head & Neck Oncology Non-Small Cell Lung Cancer – Metastatic — Christina Baik, MD, MPH
• Thoracic, Head & Neck Oncology Small Cell Lung Cancer — Nicholas Giustini, MD

Objectives

1. Describe the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common malignant hematological diseases.
2. Explain the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common solid tumor malignancies.
3. Integrate guideline-based treatments into clinical practice while personalizing care appropriately for the patient.
4. Organize new therapeutic and diagnostic approaches into clinical practice as appropriate.

Speakers

This course features expert faculty from Fred Hutchinson Cancer Center and the University of Washington School of Medicine specializing in hematology and oncology. Contributors include clinicians and researchers with diverse subspecialty expertise, offering clinically relevant, evidence-based insights on a wide range of hematologic and solid tumor malignancies, as well as supportive care disciplines.

Target Audience

This course is designed for hematologists, oncologists, oncology advanced practitioners, fellows, residents, and other healthcare professionals involved in the management of patients with hematologic disorders and solid tumors. It is also appropriate for those preparing for certification or recertification exams in hematology/oncology.

Why This Topic Matters

The 15th Annual On-Demand Comprehensive Hematology & Oncology Review Course addresses the evolving landscape of hematologic and solid tumor malignancies, providing critical updates on diagnostic and therapeutic strategies. Maintaining current knowledge in these areas is essential to deliver guideline-based, personalized care within oncology practice.

By engaging with this course via MedHub Central, healthcare professionals can strengthen their clinical expertise and confidence in managing complex hematology and oncology cases. The course supports ongoing professional development aligned with current standards in these specialties.